Abg Innovation Capital Partners Iii Gp Ltd is an investment fund managing more than $860 million ran by Fan Yu. There are currently 3 companies in Yu’s portfolio. The largest investments include Castle Biosciences and Aadi Biosciences Inc, together worth $839 million.
As of 7th August 2024, Abg Innovation Capital Partners Iii Gp Ltd’s top holding is 36,747 shares of Castle Biosciences currently worth over $800 million and making up 93.1% of the portfolio value.
Relative to the number of outstanding shares of Castle Biosciences, Abg Innovation Capital Partners Iii Gp Ltd owns more than approximately 0.1% of the company.
In addition, the fund holds 26,666 shares of Aadi Biosciences Inc worth $38.9 million.
The third-largest holding is Synlogic Inc worth $20.6 million.
Currently, Abg Innovation Capital Partners Iii Gp Ltd's portfolio is worth at least $860 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Abg Innovation Capital Partners Iii Gp Ltd office and employees reside in Hong Kong, Hong Kong. According to the last 13-F report filed with the SEC, Fan Yu serves as the Director at Abg Innovation Capital Partners Iii Gp Ltd.
In the most recent 13F filing, Abg Innovation Capital Partners Iii Gp Ltd revealed that it had increased its stake in Castle Biosciences and bought 3,121 additional shares worth around $86 thousand. This means they effectively own approximately 0.1% of the company. Castle Biosciences makes up 97.5% of the fund's Health Care sector allocation and has grown its share price by 12.0% in the past year.
The two most similar investment funds to Abg Innovation Capital Partners Iii Gp Ltd are Tensile Capital Management L.P. and 1st Global Advisors. They manage $859 million and $854 million respectively.
Abg Innovation Capital Partners Iii Gp Ltd’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 95.5% of
the total portfolio value.
The fund focuses on investments in the United States as
66.7% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
33% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $351 million.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Castle Biosciences, Inc. |
9.28%
36,747
|
$799,982,000 | 93.07% |
| Aadi Biosciences Inc |
No change
26,666
|
$38,932,000 | 4.53% |
| Synlogic Inc |
No change
13,727
|
$20,591,000 | 2.40% |
| No transactions found | |||
| Showing first 500 out of 3 holdings | |||